Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 8.32588 | 95 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 8.372 | 95 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 8.61435 | 95 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 9.59732 | 97 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 8.26128 | 94 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 7.97557 | 94 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 7.7044 | 93 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 8.10905 | 94 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 8.10843 | 94 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 7.69954 | 92 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 7.57467 | 92 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 8.08674 | 94 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 7.82859 | 93 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 7.88436 | 93 |